Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


New Leaf Ventures II, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2021 SC 13G/A New Leaf Ventures II, L.P. reports a 0% stake in Neuronetics, Inc.
02/12/2020 SC 13G/A New Leaf Ventures II, L.P. reports a 5.6% stake in Neuronetics, Inc.
02/12/2020 SC 13G/A New Leaf Ventures II, L.P. reports a 2.9% stake in Principia Biopharma Inc.
08/15/2019 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Sold 250,009 shares @ $35, valued at $8.8M
Sold 49,991 shares @ $35, valued at $1.7M
02/13/2019 SC 13G New Leaf Ventures II, L.P. reports a 11.1% stake in Principia Biopharma Inc.
02/13/2019 SC 13G New Leaf Ventures II, L.P. reports a 8.8% stake in Neuronetics, Inc.
09/20/2018 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Principia Biopharma Inc.
Txns: Converted 1,070,771 shares @ $0
Converted 312,741 shares @ $0
Converted 260,617 shares @ $0
Converted 544,047 shares @ $0
Converted 167,537 shares @ $0
Bought 270,000 shares @ $17, valued at $4.6M
Converted 1,070,771 convertible preferred @ $0
Converted 312,741 convertible preferred @ $0
Converted 260,617 convertible preferred @ $0
Converted 544,047 convertible preferred @ $0
Converted 167,537 convertible preferred @ $0
09/13/2018 3 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 3 on Principia Biopharma Inc.
07/05/2018 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Neuronetics, Inc.
Txns: Converted 848,360 shares @ $0
Converted 206,380 shares @ $0
Converted 421,681 shares @ $0
Converted 66,694 shares @ $0
Converted 848,360 convertible preferred @ $0
Converted 206,380 convertible preferred @ $0
Converted 421,681 convertible preferred @ $0
Converted 66,694 convertible preferred @ $0
06/27/2018 3 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 3 on Neuronetics, Inc.
08/21/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/06/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/28/2017 SC 13D/A Versartis, Inc. has filed a Schedule 13D for Versartis, Inc.
02/10/2017 SC 13G New Leaf Ventures II, L.P. reports a 8.2% stake in iRhythm Technologies, Inc.
11/14/2016 SC 13D/A Versartis, Inc. reports a 5.9% stake in Versartis, Inc.
10/25/2016 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on iRhythm Technologies, Inc.
10/19/2016 3 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 3 on iRhythm Technologies, Inc.
03/26/2015 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on MEI Pharma, Inc.
Txns: Sold 1,601,390 shares @ $1.9734, valued at $3.2M
12/22/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Versartis, Inc.
12/10/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on MEI Pharma, Inc.
Txns: Sold 9,004 shares @ $6.0523, valued at $54.5k
Sold 70,081 shares @ $6.0085, valued at $421.1k
11/18/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc.
11/13/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Versartis, Inc.
10/01/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Versartis, Inc.
03/28/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on Versartis, Inc.
03/20/2014 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on CHIMERIX INC
12/03/2013 4 New Leaf Ventures II, L.P. (Director) has filed a Form 4 on Oxford Immunotec Global PLC
11/25/2013 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on MEI Pharma, Inc.
Txns: Sold 365,000 shares @ $8.25, valued at $3M
11/06/2013 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/23/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/08/2013 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on MEI Pharma, Inc.
04/22/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
04/16/2013 4 New Leaf Ventures II, L.P. (10% Owner) has filed a Form 4 on CHIMERIX INC
Txns: Converted 2,410,551 shares @ $0
Converted 8,557,458 preferred shares @ $0
02/20/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
08/13/2012 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy